Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
28 Mar 2026
AAD 2026: Four Years of Secukinumab Sustains HS Control
Continuous secukinumab treatment showed sustained hidradenitis suppurativa lesion control through 4 years in responding patients.
28 Mar 2026
Nirsevimab Linked to Lower RSV Hospitalization
Nirsevimab was linked to fewer RSV hospitalizations and severe neonatal outcomes than maternal RSVpreF vaccination in France.
27 Mar 2026
AAD 2026: Remibrutinib Shows Early CSU Symptom Relief
Remibrutinib improved itch and hive severity within 12 hours in chronic spontaneous urticaria in Phase III analysis.
27 Mar 2026
Cerebral Lymphatic Therapy Advances Alzheimer’s Disease
Cerebral lymphatic dysfunction is emerging as a promising therapeutic target in Alzheimer’s disease treatment and research.
27 Mar 2026
Smart Control of CAR T Cells
Smart control of CAR T cells is advancing cancer immunotherapy by improving precision, safety, and adaptability.
26 Mar 2026
ECMO Mortality Risk Factors Revealed Nationwide
A nationwide cohort study found high in-hospital mortality among adults receiving ECMO, with risk shaped by age and comorbidity
26 Mar 2026
Botulinum Toxin Type A Linked to Serum Sickness
Serum sickness after botulinum toxin type A may signal a rare delayed systemic immune reaction. Read more.
10
Mins
26 Mar 2026
Updates in Chronic Hepatitis B Care
A large portion of the session focused on what the guidelines referred to as the “indeterminate phase” or “grey zone” of CHB, a term…
March 2026
AMJ Microbiology & Infectious Diseases 4 [Supplement 2] 2026
Chronic hepatitis B affects approximately 1.7 million people in the United States and represents a significant public health challenge…
26 Mar 2026
Meningitis Outbreak Highlights Vaccination Importance
A deadly meningitis outbreak in the U.K. has renewed focus on vaccination, early treatment, and outbreak prevention.
←
1
2
3
…
18
19
20
21
22
23
24
…
196
197
198
→
We’ve noticed you’re accessing
from
North/South America.
View
View